The Prevalence of Left Ventricular Hypertrophy Among Type-2 Diabetes Mellitus Patients
Keywords:
Hypertension, Left ventricular hypertrophy, LVH, Prevalence, Type-2 diabetes mellitus, T2DMAbstract
Background: Left ventricular hypertrophy (LVH) is a common cardiovascular alteration in individuals with type-2 diabetes mellitus. The chronic metabolic disturbances caused by diabetes, such as hyperglycemia and insulin resistance, lead to structural and functional changes in the heart. This study aimed to determine the prevalence of left ventricular hypertrophy among patients with type-2 diabetes mellitus. Methods: This prospective observational study was conducted in the Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, from June 2022 to May 2023. 87 patients diagnosed with type-2 diabetes mellitus, aged 20 to 70, were enrolled using a purposive sampling technique. Demographic and clinical data were recorded, and MS Office tools were used for data analysis. Results: In our study, most patients (55.2%) were aged 60 and above, with nearly one-third in the 45-59 age group. Regarding left ventricular geometry, we found eccentric left ventricular hypertrophy (LVH) in 42% of patients and concentric LVH in 30%. Regular left ventricular geometry was observed in 20% of the cases. In this study, the prevalence of left ventricular hypertrophy was 72%. Conclusion: Among patients with type 2 diabetes mellitus (T2DM), the prevalence of left ventricular hypertrophy (LVH) is alarmingly high, with a slightly higher frequency of eccentric LVH compared to concentric LVH. T2DM and LVH most likely have a reciprocal relationship, meaning that each illness may impact the onset or course of the other
Downloads
Metrics
References
WHO. Diabetes mellitus. Fact sheet N 138.
World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016 [Internet]. 2016
Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock G, Qiao Q, Lewington S, Di Angelantonio E. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PloS one. 2013 Jul 30;8(7): e65174.
Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. The Lancet. 2006 Nov 11;368(9548):1651-9.
Santra S, Basu AK, Roychowdhury P, Banerjee R, Singhania P, Singh S, Datta UK. Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population. Journal of cardiovascular disease research. 2011 Jan 1;2(1):50-6.
Association AD. Standards of medical care in diabetes—2013. Diabetes care. 2013;36(Supplement_1): S11–S66.
Passarella P, Kiseleva TA, Valeeva FV, Gosmanov AR. Hypertension management in diabetes: 2018 update. Diabetes Spectrum. 2018 Aug 1;31(3):218-24.
Akhter J, Ahmed A, Mawani M, Lakhani L, Kalsekar A, Tabassum S, Islam N. Patterns, control and complications of diabetes from a hospital-based registry established in a low-income country. BMC endocrine disorders. 2017 Dec; 17:1-0.
Tekalegn Y, Addissie A, Kebede T, Ayele W. Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. PloS one. 2018 Mar 5;13(3): e0193442.
Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia. 2005 Oct; 48:1971-9.
Parsa N, Moheb M, Zibaeenezhad MJ, Karimi-Akhormeh A, Trevisan M, Wallin L, Zaheri PM, Sayadi M, Razeghian-Jahromi I, Moaref A. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study. BMC Cardiovascular Disorders. 2023 Feb 15;23(1):88.
Nardi E, Palermo A, Mule G, Cusimano P, Cerasola G, Rini GB. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram. European journal of preventive cardiology. 2013 Oct 1;20(5):854-61.
Jobe M, Kane A, Jones JC, Pessinaba S, Nkum BC, Ba SA, Nyan OA. Electrocardiographic left ventricular hypertrophy among gambian diabetes mellitus patients. Ghana medical journal. 2015;49(1):19-24.
Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. American heart journal. 1997 Jan 1;133(1):36-43.
Seto Y, Nagao M, Iino T, Harada A, Murakami K, Miwa K, Shinohara M, Nishimori M, Yoshikawa S, Asakura J, Fujioka T. Impaired Cholesterol Uptake Capacity in Patients with Hypertriglyceridemia and Diabetes Mellitus. The Journal of Applied Laboratory Medicine. 2024 Jul;9(4):728-40.
Lv J, Liu Y, Yan Y, Sun D, Fan L, Guo Y, Fernandez C, Bazzano L, He J, Li S, Chen W. Relationship between left ventricular hypertrophy and diabetes is likely bidirectional: a temporality analysis. Journal of the American Heart Association. 2023 Mar 21;12(6): e028219.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
